Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|September 20, 2017
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous FungiAmit V Desai, Laura L Kovanda, William W Hope, et al.
Infection and Immunity|October 13, 2006
GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulenceJin Woo Bok, DaWoon Chung, S Arunmozhi Balajee, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized PatientsDavid Andes, Nkechi Azie, Hongbo Yang, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2011
Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemiaDavid Andes, Paul G Ambrose, Jeffrey P Hammel, et al.
Plos Pathogens|September 19, 2014
Comparative phenotypic analysis of the major fungal pathogens Candida parapsilosis and Candida albicansLinda M Holland, Markus S Schröder, Siobhán A Turner, et al.
Research Square|January 27, 2025
Structure-guided optimization of small molecules targeting the yeast casein kinase, Yck2, as a therapeutic strategy to combat Candida albicansLeah Cowen, Emily Puumala, Meganathan Nandakumar, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Altered oral microbiota of drug-resistant organism carriers exhibit impaired gram-negative pathogen inhibitionSusan Zelasko, Mary-Hannah Swaney, Won Se Suh, et al.
Infection and Immunity|June 23, 2006
Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanismPranab K Mukherjee, Sotohy Mohamed, Jyotsna Chandra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Plasma microbial cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High Risk Outpatient and Inpatient Immunocompromised HostsBeatrice Z Sim, Jordan K Mah, Madeleine R Heldman, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2024
Outcomes by <i>Candida</i> spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasisJeffrey B Locke, Chris M Pillar, Mariana Castanheira, et al.
Pageof 10